Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neoadjuvant endocrine therapy models.

Juliette Murray1, William R Miller, J Michael Dixon

  • 1Edinburgh Breast Unit, Western General Hospital, UK.

Methods in Molecular Medicine
|February 24, 2006
PubMed
Summary

Neoadjuvant therapy, given before surgery, aims to shrink large breast tumors. This approach, often using chemotherapy or endocrine therapy, facilitates less radical surgical excision and is assessed through repeat biopsies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Virga and the future of motivational interviewing: Issues in training counseling skills.

Patient education and counseling·2026
Same author

R pyocin sensitivity of <i>Pseudomonas aeruginosa</i> clinical isolates from different disease types.

Journal of medical microbiology·2026
Same author

International consensus on axillary staging after neoadjuvant chemotherapy in node-positive breast cancer.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Same author

Genomic and Clinical Features Associated with Reduced Susceptibility to Cefiderocol and Cross-resistance to β-lactam/β-lactamase Inhibitors in a Global Cohort of Pseudomonas aeruginosa.

The Journal of infectious diseases·2026
Same author

Reply to White and Siegrist, "Multi-drug-resistant enterococcal infections: duration of combination therapy and OPAT challenges".

Antimicrobial agents and chemotherapy·2026
Same author

Loss of the ferripyochelin receptor FptA drives reduced cefiderocol susceptibility and impairs fitness in <i>Pseudomonas aeruginosa</i> PA14.

Antimicrobial agents and chemotherapy·2026

Area of Science:

  • Oncology
  • Surgical Oncology
  • Clinical Trial Design

Background:

  • Neoadjuvant therapy is administered before surgical intervention for breast cancer.
  • It is primarily used for large, locally advanced tumors to reduce tumor size.
  • Chemotherapy is common, with increasing use of endocrine therapy for hormone-sensitive tumors.

Purpose of the Study:

  • To describe essential protocols for designing neoadjuvant trials.
  • To detail methods for assessing response to neoadjuvant therapy.
  • To present approaches for collecting and assessing clinical samples during neoadjuvant therapy.

Main Methods:

  • Designing clinical trial protocols for neoadjuvant therapy.
  • Utilizing repeat biopsies to assess treatment response (e.g., estrogen receptor status, proliferation markers).
  • Developing strategies for clinical sample collection and analysis.

Main Results:

  • Established protocols for neoadjuvant trial design.
  • Detailed methods for evaluating treatment response.
  • Presented approaches for clinical sample assessment.

Conclusions:

  • Neoadjuvant therapy offers a strategy to downstage locally advanced breast tumors.
  • Effective trial design and response assessment are crucial for neoadjuvant therapy.
  • Clinical sample analysis provides insights into treatment efficacy and tumor biology.

Related Experiment Videos